Valuation: ResMed, Inc.

Market Cap 3.06TCr 2.64TCr 2.47TCr 2.27TCr 4.26TCr 2,91000Cr 4.33TCr 29TCr 11TCr 1,45800Cr 11TCr 11TCr 4,82100Cr P/E 2026
18.7x
P/E 2027 * 18.4x
Enterprise Value 2.97TCr 2.57TCr 2.4TCr 2.2TCr 4.14TCr 2,82600Cr 4.2TCr 28TCr 11TCr 1,41600Cr 11TCr 11TCr 4,68300Cr EV / Sales 2026
4.84x
EV / Sales 2027 * 5.1x
Free-Float
37.81%
Yield 2026
1.26%
Yield 2027 * 1.26%
1 day-5.06%
1 week+0.46%
Current month+0.46%
1 month+1.67%
3 months+2.51%
6 months-23.20%
Current year-12.01%
1 week 202
Extreme 202
226.12
1 month 190.21
Extreme 190.21
226.12
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
09/02/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-5.06%+0.46%-25.35%+19.79% 3.06TCr
+2.41%+3.43%+28.93%+8.48% 22TCr
+2.39%+5.02%+2.09%-20.03% 14TCr
+1.36%+7.21%-19.42%+24.57% 13TCr
+0.02%+5.52%-52.19%-3.43% 7.15TCr
+0.45%+4.24%+14.51%+15.07% 5.17TCr
-1.20%+0.03%-14.75%-18.26% 5.08TCr
+3.28%+5.49%+27.35%+14.37% 4.12TCr
+1.79%+7.83%+44.69%+39.33% 3.99TCr
+2.08%+5.51%-0.32%-2.91% 3.24TCr
Average +0.80%+5.19%+0.55%+7.70% 8.16TCr
Weighted average by Cap. +1.44%+5.09%+3.01%+5.57%

Financials

2026 2027 *
Net sales 564.84Cr 488.59Cr 456.27Cr 418.56Cr 787.26Cr 54TCr 799.76Cr 5.35TCr 2.1TCr 27TCr 2.12TCr 2.07TCr 89TCr 580.13Cr 501.81Cr 468.61Cr 429.89Cr 808.56Cr 55TCr 821.4Cr 5.5TCr 2.16TCr 28TCr 2.18TCr 2.13TCr 91TCr
Net income 154.05Cr 133.26Cr 124.44Cr 114.16Cr 214.71Cr 15TCr 218.13Cr 1.46TCr 573.05Cr 7.35TCr 578.5Cr 565.84Cr 24TCr 162.87Cr 140.89Cr 131.57Cr 120.69Cr 227.01Cr 16TCr 230.61Cr 1.54TCr 605.86Cr 7.77TCr 611.63Cr 598.24Cr 26TCr
Net Debt -88Cr -76Cr -71Cr -65Cr -122.24Cr -8.35TCr -124.18Cr -831.2Cr -326.24Cr -4.18TCr -329.35Cr -322.14Cr -14TCr -96Cr -83Cr -78Cr -71Cr -134.35Cr -9.17TCr -136.49Cr -913.57Cr -358.57Cr -4.6TCr -361.98Cr -354.06Cr -15TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
07/26/07 $211.94 -5.06% 38,10,438
06/26/06 $223.24 -0.35% 17,86,085
05/26/05 $224.03 +0.40% 17,46,578
04/26/04 $223.14 +3.69% 17,42,551
03/26/03 $215.19 +2.00% 14,66,073
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
211.94USD
Average target price
247.20USD
Spread / Average Target
+16.64%

Quarterly revenue - Rate of surprise